**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 393-75-9 |4-Chloro-3,5-Dinitrobenzotrifluoride | 98% | 206-889-3 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: XN
Risk Phrases: 22 36/37/38
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Harmful if swallowed. Irritating to eyes, respiratory system and
skin.
Potential Health Effects
Eye:
Causes eye irritation. May cause chemical conjunctivitis.
Skin:
Causes skin irritation. May be fatal if absorbed through the skin.
May be harmful if absorbed through the skin.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and
diarrhea. May cause methemoglobinemia, cyanosis (bluish
discoloration of skin due to deficient oxygenation of the blood),
convulsions, and death. May be harmful if swallowed.
Inhalation:
Causes respiratory tract irritation. May cause methemoglobinemia,
cyanosis (bluish discoloration of skin due to deficient oxygenation
of the blood), convulsions, tachycardia, dyspnea (labored
breathing), and death. Can produce delayed pulmonary edema.
Chronic:
May cause methemoglobinemia, which is characterized by
chocolate-brown colored blood, headache, weakness, dizziness, breath
shortness, cyanosis (bluish skin due to deficient oxygenation of
blood), rapid heart rate, unconsciousness and possible death. Effects
may be delayed.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Immediately flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15
minutes while removing contaminated clothing and shoes. Wash clothing
before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical
aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and
drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If breathing
is difficult, give oxygen. Get medical aid. Do NOT use mouth-to-mouth
resuscitation. If breathing has ceased apply artificial respiration
using oxygen and a suitable mechanical device such as a bag and a
mask.
Notes to Physician:
For methemoglobinemia, administer oxygen alone or with Methylene
Blue depending on the methemoglobin concentration in the blood.
Antidote:
Methylene blue, alone or in combination with oxygen is indicated as
a treatment in nitrite induced methemoglobinemia.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion. Runoff from
fire control or dilution water may cause pollution.
Extinguishing Media:
Use agent most appropriate to extinguish fire. Use water spray, dry
chemical, carbon dioxide, or appropriate foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal
container. Clean up spills immediately, observing precautions in the
Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Remove contaminated clothing and
wash before reuse. Minimize dust generation and accumulation. Avoid
contact with eyes, skin, and clothing. Keep container tightly closed.
Avoid ingestion and inhalation. Use with adequate ventilation.
Storage:
Store in a tightly closed container. Store in a cool, dry,
well-ventilated area away from incompatible substances.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate
ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 393-75-9:
United States OSHA: 2.5 mg/m3 TWA (as F) (listed under Fluorides
Russia: 0.05 mg/m3 TWA
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Use a
NIOSH/MSHA or European Standard EN 149 approved
respirator if exposure limits are exceeded or if
irritation or other symptoms are experienced.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Crystals
Color: yellow
Odor: None reported.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 56.00 - 58.00 deg C
Autoignition Temperature: Not applicable.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature: >300 deg C
Solubility in water: soluble in methanol
Specific Gravity/Density:
Molecular Formula: C7H2ClF3N2O4
Molecular Weight: 270.54
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable at room temperature in closed containers under normal storage
and handling conditions.
Conditions to Avoid:
Incompatible materials, dust generation, excess heat, strong
oxidants.
Incompatibilities with Other Materials:
Oxidizing agents, strong bases.
Hazardous Decomposition Products:
Hydrogen chloride, nitrogen oxides, carbon monoxide, irritating and
toxic fumes and gases, carbon dioxide, hydrogen fluoride gas,
nitrogen.
Hazardous Polymerization: Has not been reported.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 393-75-9: XS9065000
LD50/LC50:
CAS# 393-75-9: Oral, rat: LD50 = 930 mg/kg; Skin, rabbit: LD50 = 161
mg/kg.
Carcinogenicity:
4-Chloro-3,5-Dinitrobenzotrifluoride -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 22 Harmful if swallowed.
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 393-75-9: No information available.
Canada
CAS# 393-75-9 is listed on Canada's NDSL List.
CAS# 393-75-9 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 393-75-9 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 9/02/1997 Revision #4 Date: 3/18/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
2-Amino-1,3-Propanediol, 98%
| 534-03-2 |
|
1,7-Octadiene, 98.5%
| 3710-30-3 |
|
(2-Bromoethyl)benzene, 98%
| 103-63-9 |
|
4-Piperidinopiperidine, tech., 95%
| 4897-50-1 |
|
4'-Bromopropiophenone, 97%
| 10342-83-3 |
|
Thiophenol
| 108-98-5 |
|
1,2,4-Trivinylcyclohexane, 98% mixture of isomers
| 2855-27-8 |
|
l-Bornyl acetate
| 5655-61-8 |
|
Cyclopentadecanone, 96%
| 502-72-7 |
|
1,14-Tetradecanediol, 95% (GC)
| 19812-64-7 |
|
3-Heptylthiophene, 97%
| 65016-61-7 |
|
2,4-Dimethyl-6-Hydroxypyrimidine, 99+%
| 6622-92-0 |
|
3-(2-Chloroethyl)-2,4(1H,3H)-Quinazoline- Dione, 99%
| 5081-87-8 |
|
3,5-Dimethyl-4-heptanone, 97+%
| 19549-84-9 |
|
N-Methyl-p-anisidine, 98%
| 5961-59-1 |
|
m-Toluenethiol, 97% (GC)
| 108-40-7 |
|
Dehydroabietylamine, tech.
| 1446-61-3 |
|
Zirconium atomic absorption standard solution, 1 mg/ml Zr in 5% HF
| 7440-67-7 |
|
DL-Bromosuccinic Acid, 96%
| 923-06-8 |
|
3-Chloropropiophenone, 98%
| 936-59-4 |
|
Hexadecyltrimethylammonium chloride, 99%
| 112-02-7 |
|
2,5-Dichlorothiophene, 98%
| 3172-52-9 |
|
Stigmastanol, Tech.
| 19466-47-8 |
|
3-Acetamido-4-methoxybenzenesulfinic acid, hydrate, 97%
| |
|
2,4-Dinitrobenzenesulfonic Acid Sodium Salt, 98% (UV-Vis)
| 885-62-1 |
|
2-Methylindole, 98%
| 95-20-5 |
|
(R)-(+)-2-Chloropropionic acid, 98%
| 598-78-7 |
|
m-Phosphoric Acid, Glacial
| 37267-86-0 |
|
2-Ethylhexyl acrylate, 99+% stabilized with 10-20 ppm MEHQ
| 103-11-7 |
|
2-Chloropropane, P.A.
| 75-29-6 |
|
m-Xylene
| 108-38-3 |
|
4-Chloro-3,5-Dinitrobenzotrifluoride 98+%
| 393-75-9 |
|
Crotyl bromide, 85 %(gc-cap.), remainder 3-bromo-1-butene
| 29576-14-5 |
|
n-Dodecyl sulfide, 93%
| 2469-45-6 |
|
6-Nitropiperonyl Alcohol, 98%
| 15341-08-9 |
|
Methyl 2-methoxybenzoate, 99%
| 606-45-1 |
|
Magnesium, turnings and ribbons
| 7439-95-4 |
|
Magnesium acetate tetrahydrate
| 16674-78-5 |
|
Formaldoxime Trimer Hydrochloride
| 62479-72-5 |
|
4-Ethoxy-1,3-Phenylenediamine Dihydro-Chloride, 98%
| 67801-06-3 |
|
Erbium atomic absorption standard solution, 1 mg/ml Er in 2% HNO3
| 7440-52-0 |
|
Dithiothreitol, 99%
| 3483-12-3 |
|
2,5-Dichloroaniline, 99%
| 95-82-9 |
|
Dimesitylcyclopropenone, 99% (uv-vis)
| 61440-88-8 |
|
Alpha-Cyclodextrin Hydrate, 98+% (HPLC)
| 10016-20-3 |
|
Magnesium Bromide Hexahydrate
| 13446-53-2 |
|
Magnesium carbonate anhydrous
| 546-93-0 |
|
Silver cyanate
| 3315-16-0 |
|
2,3,4,6-Tetra-o-acetyl-alpha-d-glucopyranosyl azide, 95%
| 20369-61-7 |
|
Magnesium Chloride Hexahydrate
| 7791-18-6 |
|
|